Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Trigriluzole |
| Synonyms | |
| Therapy Description |
Trigriluzole (BHV-4157) is a small molecule inhibitor of the metabotropic glutamate receptor 1 (GRM1), which may prevent tumor growth (Journal of Clinical Oncology 36, no. 5_suppl, TPS80). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Trigriluzole | BHV-4157|BHV4157|Troriluzole | Trigriluzole (BHV-4157) is a small molecule inhibitor of the metabotropic glutamate receptor 1 (GRM1), which may prevent tumor growth (Journal of Clinical Oncology 36, no. 5_suppl, TPS80). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06552260 | Phase I | Trigriluzole | A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma | Recruiting | USA | 0 |